---
schema_version: "secwatch.filing_event.v1"
accession: "0001764013-22-000108"
form_type: "8-K"
ticker: "IMVT"
cik: "0001764013"
company_name: "Immunovant, Inc."
filed_at: "2022-08-19T23:59:59+00:00"
generated_at: "2026-06-23T22:35:09.725335+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Immunovant stockholders elect directors, ratify auditor, approve say-on-pay at 2022 annual meeting

## Summary
- Three directors elected: Peter Salzmann, Douglas Hughes, George Migausky — all with >90M votes for.
- Ernst & Young LLP ratified as independent auditor for FY ending March 31, 2023 (105.8M for, 33k against).
- Non-binding advisory approval of named executive officer compensation passed with 87.5M for, 14.8M against.
- Approximately 91% of shares entitled to vote were represented at the meeting.

## SEC filing metadata
- accession: 0001764013-22-000108
- form_type: 8-K
- ticker: IMVT
- cik: 0001764013
- company_name: Immunovant, Inc.
- filed_at: 2022-08-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764013/000176401322000108/0001764013-22-000108-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764013/000176401322000108/imvt-20220817x8xk.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001764013-22-000108
- JSON: https://secwatch.observer/filing/0001764013-22-000108.json
- Plain text: https://secwatch.observer/filing/0001764013-22-000108.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.